Salvadori Daniel Gesua Sive's Form 4 filing
Abbott Laboratories (ABT) · filed Jan 31, 2025
- Accession no.
- 0001415889-25-002584
- Filed
- Jan 31, 2025
- Trade date
- Jan 30, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.05M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Salvadori Daniel Gesua SiveCIK 0001620564 | Officer (EXECUTIVE VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | Common shares without par value | MOption exerciseAcquired | +23,771 | $38.40 | +$912,806.4 | 149,468 | Direct | |
| Jan 30, 2025 | Common shares without par value | SSaleDisposed | −23,771 | $128.50 | −$3,054,573.5 | 125,697 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | Common Shares | MOption exerciseDisposed | −23,771 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.